Stephen A McClave1,2, Jill Gualdoni3, Annie Nagengast4, Luis S Marsano3, Kathryn Bandy3, Robert G Martindale4. 1. Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA. samcclave@louisville.edu. 2. Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, 550 South Jackson Street, Louisville, KY, 40202, USA. samcclave@louisville.edu. 3. Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA. 4. Department of Surgery, Oregon Health Sciences University, Portland, OR, USA.
Abstract
PURPOSE OF REVIEW: Efforts to provide early enteral nutrition in critical illness are thwarted by gastrointestinal dysfunction and feeding intolerance. While many of the signs and symptoms of this dysfunction reflect gastroparesis and intestinal dysmotility, other symptoms which may or may not be related are often included such as diarrhea, bleeding, and intra-abdominal hypertension. This paper discusses the need to monitor tolerance of nutritional therapy in the critical care setting and reviews the results of those clinical trials which have helped establish objective measures, define feeding intolerance, and provide a tool to guide continued delivery of the enteral regimen. RECENT FINDINGS: While definitions vary, the presence of gastrointestinal dysfunction and feeding intolerance correlates with adverse clinical outcomes, including prolonged duration of mechanical ventilation, greater length of stay in the intensive care unit, and increased mortality. Despite their prognostic value, it is not clear to what extent these scoring systems should direct nutritional therapy. The clinician should be astute in the careful selection of monitors, in identifying and addressing signs and symptoms of intolerance, and by responding appropriately with feeding strategies that are effective and safe. Early enteral feeding in critical illness has been shown to be optimized by following protocols which allow monitoring patient tolerance while providing individualized care.
PURPOSE OF REVIEW: Efforts to provide early enteral nutrition in critical illness are thwarted by gastrointestinal dysfunction and feeding intolerance. While many of the signs and symptoms of this dysfunction reflect gastroparesis and intestinal dysmotility, other symptoms which may or may not be related are often included such as diarrhea, bleeding, and intra-abdominal hypertension. This paper discusses the need to monitor tolerance of nutritional therapy in the critical care setting and reviews the results of those clinical trials which have helped establish objective measures, define feeding intolerance, and provide a tool to guide continued delivery of the enteral regimen. RECENT FINDINGS: While definitions vary, the presence of gastrointestinal dysfunction and feeding intolerance correlates with adverse clinical outcomes, including prolonged duration of mechanical ventilation, greater length of stay in the intensive care unit, and increased mortality. Despite their prognostic value, it is not clear to what extent these scoring systems should direct nutritional therapy. The clinician should be astute in the careful selection of monitors, in identifying and addressing signs and symptoms of intolerance, and by responding appropriately with feeding strategies that are effective and safe. Early enteral feeding in critical illness has been shown to be optimized by following protocols which allow monitoring patient tolerance while providing individualized care.
Authors: Stephen A McClave; Beth E Taylor; Robert G Martindale; Malissa M Warren; Debbie R Johnson; Carol Braunschweig; Mary S McCarthy; Evangelia Davanos; Todd W Rice; Gail A Cresci; Jane M Gervasio; Gordon S Sacks; Pamela R Roberts; Charlene Compher Journal: JPEN J Parenter Enteral Nutr Date: 2016-02 Impact factor: 4.016
Authors: S A McClave; H L Snider; C C Lowen; A J McLaughlin; L M Greene; R J McCombs; L Rodgers; R A Wright; T M Roy; M P Schumer Journal: JPEN J Parenter Enteral Nutr Date: 1992 Mar-Apr Impact factor: 4.016
Authors: S A McClave; L K Sexton; D A Spain; J L Adams; N A Owens; M B Sullins; B S Blandford; H L Snider Journal: Crit Care Med Date: 1999-07 Impact factor: 7.598
Authors: Adam M Deane; Matthew J Summers; Antony V Zaknic; Marianne J Chapman; Anna E Di Bartolomeo; Max Bellon; Anne Maddox; Antoinette Russo; Michael Horowitz; Robert J L Fraser Journal: Crit Care Med Date: 2011-06 Impact factor: 7.598
Authors: Stephen A McClave; James K Lukan; James A Stefater; Cynthia C Lowen; Stephen W Looney; Paul J Matheson; Kevin Gleeson; David A Spain Journal: Crit Care Med Date: 2005-02 Impact factor: 7.598
Authors: Stephen A McClave; Mohamed A Saad; Mark Esterle; Mary Anderson; Alice E Jotautas; Glen A Franklin; Daren K Heyland; Ryan T Hurt Journal: JPEN J Parenter Enteral Nutr Date: 2014-06-18 Impact factor: 4.016
Authors: P L M Lakenman; J C van Schie; B van der Hoven; S J Baart; R D Eveleens; J van Bommel; J F Olieman; K F M Joosten Journal: Clin Nutr Date: 2022-04-06 Impact factor: 7.643
Authors: Jean-Charles Preiser; Yaseen M Arabi; Mette M Berger; Michael Casaer; Stephen McClave; Juan C Montejo-González; Sandra Peake; Annika Reintam Blaser; Greet Van den Berghe; Arthur van Zanten; Jan Wernerman; Paul Wischmeyer Journal: Crit Care Date: 2021-12-14 Impact factor: 9.097